Article Versions Notes

Belenchia AM, Boukhalfa A, DeMarco VG, Mehm A, Mahmood A, Liu P, Tang Y, Gavini MP, Mooney B, Chen HH, et al. Cardiovascular Protective Effects of NP-6A4, a Drug with the FDA Designation for Pediatric Cardiomyopathy, in Female Rats with Obesity and Pre-Diabetes. Cells. 2023; 12(10):1373. https://doi.org/10.3390/cells12101373

Belenchia, Anthony M., Asma Boukhalfa, Vincent G. DeMarco, Alexander Mehm, Abuzar Mahmood, Pei Liu, Yinian Tang, Madhavi P. Gavini, Brian Mooney, Howard H. Chen, and et al. 2023. "Cardiovascular Protective Effects of NP-6A4, a Drug with the FDA Designation for Pediatric Cardiomyopathy, in Female Rats with Obesity and Pre-Diabetes" Cells 12, no. 10: 1373. https://doi.org/10.3390/cells12101373

Belenchia, A. M., Boukhalfa, A., DeMarco, V. G., Mehm, A., Mahmood, A., Liu, P., Tang, Y., Gavini, M. P., Mooney, B., Chen, H. H., & Pulakat, L. (2023). Cardiovascular Protective Effects of NP-6A4, a Drug with the FDA Designation for Pediatric Cardiomyopathy, in Female Rats with Obesity and Pre-Diabetes. Cells, 12(10), 1373. https://doi.org/10.3390/cells12101373